12-50640803-G-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The NM_173602.3(DIP2B):c.252G>T(p.Lys84Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,613,854 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_173602.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DIP2B | NM_173602.3 | c.252G>T | p.Lys84Asn | missense_variant | 3/38 | ENST00000301180.10 | NP_775873.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DIP2B | ENST00000301180.10 | c.252G>T | p.Lys84Asn | missense_variant | 3/38 | 5 | NM_173602.3 | ENSP00000301180.5 | ||
DIP2B | ENST00000549620.5 | n.408G>T | non_coding_transcript_exon_variant | 3/8 | 1 | |||||
DIP2B | ENST00000546719.1 | n.-2G>T | upstream_gene_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152130Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461724Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 727178
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152130Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74304
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2024 | The c.252G>T (p.K84N) alteration is located in exon 3 (coding exon 3) of the DIP2B gene. This alteration results from a G to T substitution at nucleotide position 252, causing the lysine (K) at amino acid position 84 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at